Metabolic Research

Retatrutide 30mg

EGX-RETA-30

30 mg / vial

IN STOCKCOA AVAILABLE>99% (HPLC) PURITY

Investigational triple agonist targeting GIP, GLP-1 and glucagon pathways for advanced metabolic and energy-balance research.

Investigated mechanism

Investigational molecule that activates three receptors: GIP, GLP-1 and glucagon. These routes are studied for their relationship with satiety, glucose, energy expenditure and lipid metabolism.

Research areas

Weight regulation
Glucose and lipid metabolism
Satiety
Energy expenditure
Metabolic health

Level of evidence

Investigational molecule with human clinical trials. Not an approved product and not available for therapeutic use.

Specifications

Identity

SKU: EGX-RETA-30
Form: Lyophilized powder

Composition

Purity: >99% (HPLC)

Handling & supply

Presentation: 30 mg / vial
Storage: Store at -20 C, protect from light

Documentation

Certificate of Analysis · issued per lot

COA · PDF

Private pricing

Checking access…

Sold for research purposes only. Not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use.